Beth Israel Deaconess Medical Center (Bidmc) — Boston, Massachusetts

Public research footprint of Beth Israel Deaconess Medical Center (Bidmc), compiled from the ClinicalTrials.gov public registry.

2,298

Registered studies

617

Active

300

Recruiting now

1,283

Completed

322

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Glioblastoma Multiforme (GBM) · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIA Lung Cancer AJCC v8

Recently updated registry entries

NCT05047172 — Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular… (Active Not Recruiting)
NCT07213791 — A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (Recruiting)
NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Beth Israel Deaconess Medical Center (Bidmc)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.